Cancer Risks for PMS2-Associated Lynch Syndrome release_ygv6z7uhcrclxfwx5ugc3o3tee

by Sanne W. ten Broeke, Heleen M. van der Klift, Carli M.J. Tops, Stefan Aretz, Inge Bernstein, Daniel D. Buchanan, Albert de la Chapelle, Gabriel Capella, Mark Clendenning, Christoph Engel, Steven Gallinger, Encarna Gomez Garcia (+36 others)

Published in Journal of Clinical Oncology by American Society of Clinical Oncology (ASCO).

2018   Volume 36, Issue 29, JCO.2018.78.477


Heterozygous PMS2 mutation carriers were at small increased risk for colorectal and endometrial cancer but not for any other Lynch syndrome-associated cancer. This finding justifies that PMS2-specific screening protocols could be restricted to colonoscopies. The role of risk-reducing hysterectomy and bilateral salpingo-oophorectomy for PMS2 mutation carriers needs further discussion.
In text/plain format

Archived Files and Locations

application/pdf  908.0 kB
file_m3twnpetuva3rlcd5ajugkm6im (aggregator) (webarchive)
application/pdf  942.3 kB
file_aktamtc6pjg7rlpunzgy6dzko4 (webarchive) (web)
Read Archived PDF
Type  article-journal
Stage   published
Date   2018-08-30
Language   en ?
Journal Metadata
Not in DOAJ
In Keepers Registery
ISSN-L:  0732-183X
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 62bef614-d795-45bd-86b1-3fa473cb9369